Cargando…

5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules

The five membered heterocyclic oxazole group plays an important role in drug discovery. Oxazolones present a wide range of biological activities. In this article the synthesis of 4-substituted-2-phenyloxazol-5(4H)-ones from the appropriate substituted aldehydes via an Erlenmeyer–Plochl reaction is r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavridis, Evangelos, Bermperoglou, Eleftherios, Pontiki, Eleni, Hadjipavlou-Litina, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397336/
https://www.ncbi.nlm.nih.gov/pubmed/32664550
http://dx.doi.org/10.3390/molecules25143173
_version_ 1783565757722918912
author Mavridis, Evangelos
Bermperoglou, Eleftherios
Pontiki, Eleni
Hadjipavlou-Litina, Dimitra
author_facet Mavridis, Evangelos
Bermperoglou, Eleftherios
Pontiki, Eleni
Hadjipavlou-Litina, Dimitra
author_sort Mavridis, Evangelos
collection PubMed
description The five membered heterocyclic oxazole group plays an important role in drug discovery. Oxazolones present a wide range of biological activities. In this article the synthesis of 4-substituted-2-phenyloxazol-5(4H)-ones from the appropriate substituted aldehydes via an Erlenmeyer–Plochl reaction is reported. Subsequently, the corresponding benzamides were produced via a nucleophilic attack of a secondary amine on the oxazolone ring applying microwave irradiation. The compounds are obtained in good yields up to 94% and their structures were confirmed using IR, (1)H-NMR, (13)C-NMR and LC/MS data. The in vitro anti-lipid peroxidation activity and inhibitory activity against lipoxygenase and trypsin induced proteolysis of the novel derivatives were studied. Inhibition of carrageenin-induced paw edema (CPE) and nociception was also determined for compounds 4a and 4c. Oxazolones 2a and 2c strongly inhibit lipid peroxidation, followed by oxazolones 2b and 2d with an average inhibition of 86.5%. The most potent lipoxygenase inhibitor was the bisbenzamide derivative 4c, with IC(50) 41 μM. The benzamides 3c, 4a–4e and 5c were strong inhibitors of proteolysis. The replacement of the thienyl moiety by a phenyl group does not favor the protection. Compound 4c inhibited nociception higher than 4a. The replacement of thienyl groups by phenyl ring led to reduced biological activity. Docking studies of the most potent LOX inhibitor highlight interactions through allosteric mechanism. All the potent derivatives present good oral bioavailability.
format Online
Article
Text
id pubmed-7397336
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73973362020-08-16 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules Mavridis, Evangelos Bermperoglou, Eleftherios Pontiki, Eleni Hadjipavlou-Litina, Dimitra Molecules Article The five membered heterocyclic oxazole group plays an important role in drug discovery. Oxazolones present a wide range of biological activities. In this article the synthesis of 4-substituted-2-phenyloxazol-5(4H)-ones from the appropriate substituted aldehydes via an Erlenmeyer–Plochl reaction is reported. Subsequently, the corresponding benzamides were produced via a nucleophilic attack of a secondary amine on the oxazolone ring applying microwave irradiation. The compounds are obtained in good yields up to 94% and their structures were confirmed using IR, (1)H-NMR, (13)C-NMR and LC/MS data. The in vitro anti-lipid peroxidation activity and inhibitory activity against lipoxygenase and trypsin induced proteolysis of the novel derivatives were studied. Inhibition of carrageenin-induced paw edema (CPE) and nociception was also determined for compounds 4a and 4c. Oxazolones 2a and 2c strongly inhibit lipid peroxidation, followed by oxazolones 2b and 2d with an average inhibition of 86.5%. The most potent lipoxygenase inhibitor was the bisbenzamide derivative 4c, with IC(50) 41 μM. The benzamides 3c, 4a–4e and 5c were strong inhibitors of proteolysis. The replacement of the thienyl moiety by a phenyl group does not favor the protection. Compound 4c inhibited nociception higher than 4a. The replacement of thienyl groups by phenyl ring led to reduced biological activity. Docking studies of the most potent LOX inhibitor highlight interactions through allosteric mechanism. All the potent derivatives present good oral bioavailability. MDPI 2020-07-11 /pmc/articles/PMC7397336/ /pubmed/32664550 http://dx.doi.org/10.3390/molecules25143173 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mavridis, Evangelos
Bermperoglou, Eleftherios
Pontiki, Eleni
Hadjipavlou-Litina, Dimitra
5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title_full 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title_fullStr 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title_full_unstemmed 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title_short 5-(4H)-Oxazolones and Their Benzamides as Potential Bioactive Small Molecules
title_sort 5-(4h)-oxazolones and their benzamides as potential bioactive small molecules
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397336/
https://www.ncbi.nlm.nih.gov/pubmed/32664550
http://dx.doi.org/10.3390/molecules25143173
work_keys_str_mv AT mavridisevangelos 54hoxazolonesandtheirbenzamidesaspotentialbioactivesmallmolecules
AT bermperogloueleftherios 54hoxazolonesandtheirbenzamidesaspotentialbioactivesmallmolecules
AT pontikieleni 54hoxazolonesandtheirbenzamidesaspotentialbioactivesmallmolecules
AT hadjipavloulitinadimitra 54hoxazolonesandtheirbenzamidesaspotentialbioactivesmallmolecules